相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials
Donna M. Wilcock et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
Markus Mandler et al.
MOLECULAR NEURODEGENERATION (2015)
Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease
Kenneth E. Ugen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Dendritic cell-based vaccine efficacy: aiming for hot spots
Gabriela Andrea Pizzurro et al.
FRONTIERS IN IMMUNOLOGY (2015)
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
Markus Mandler et al.
ACTA NEUROPATHOLOGICA (2014)
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
Ariadna Recasens et al.
ANNALS OF NEUROLOGY (2014)
Regulatory T cells in cancer immunotherapy
Hiroyoshi Nishikawa et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders
Veronica Lindstrom et al.
IMMUNOTHERAPY (2014)
Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: Feasibility study
Anahit Ghochikyan et al.
NEUROSCIENCE LETTERS (2014)
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
Senthilkumar S. Karuppagounder et al.
SCIENTIFIC REPORTS (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype
Adahir Labrador-Garrido et al.
IMMUNITY INFLAMMATION AND DISEASE (2014)
Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity
Vanesa Sanchez-Guajardo et al.
ASN NEURO (2013)
α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
Vanesa Sanchez-Guajardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson's disease
Zhongmei Chen et al.
NEUROLOGICAL SCIENCES (2013)
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Elvira Valera et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Transmission of multiple system atrophy prions to transgenic mice
Joel C. Watts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular events underlying Parkinson's disease - an interwoven tapestry
Kah-Leong Lim et al.
FRONTIERS IN NEUROLOGY (2013)
The Usefulness and Challenges of Transgenic Mouse Models in the Study of Alzheimers Disease
Donna M. Wilcock
CNS & Neurological Disorders-Drug Targets (2012)
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy
Kiren Ubhi et al.
EXPERIMENTAL NEUROLOGY (2012)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
Toward a Redefinition of Parkinson's Disease
Matthew B. Stern et al.
MOVEMENT DISORDERS (2012)
Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo
Elodie Angot et al.
PLOS ONE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
The role of heat shock proteins in antigen cross presentation
Ayesha Murshid et al.
FRONTIERS IN IMMUNOLOGY (2012)
Clinico-pathological correlations in neurodegeneration
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2011)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Experimental and Clinical Application of Plasmid DNA in the Field of Central Nervous Diseases
Munehisa Shimamura et al.
CURRENT GENE THERAPY (2011)
Immunotherapy for Alzheimer's Disease: Rational Basis in Ongoing Clinical Trials
Manuel Menendez-Gonzalez et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
He-Jin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Phenylbutyrate Up-regulates the DJ-1 Protein and Protects Neurons in Cell Culture and in Animal Models of Parkinson Disease
Wenbo Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The natural history of treated Parkinson's disease in an incident, community based cohort
Jonathan R. Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Molecular chaperones in protein folding and proteostasis
F. Ulrich Hartl et al.
NATURE (2011)
Priorities in Parkinson's disease research
Wassilios G. Meissner et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Vaccination for Parkinson's disease
A. Schneeberger et al.
PARKINSONISM & RELATED DISORDERS (2011)
Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease
Anna Nemirovsky et al.
VACCINE (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
Patrice Peran et al.
BRAIN (2010)
AFFITOME® technology in neurodegenerative diseases The doubling advantage
Achim Schneeberger et al.
HUMAN VACCINES (2010)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Genome-wide association studies: the key to unlocking neurodegeneration?
Sonia Gandhi et al.
NATURE NEUROSCIENCE (2010)
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
Han Seok Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
SNCA Variants Are Associated with Increased Risk for Multiple System Atrophy
Sonja W. Scholz et al.
ANNALS OF NEUROLOGY (2009)
Exploratory activity and motor coordination in old versus middle-aged C57BL/6J mice
R. Lalonde et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2009)
Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study
G. Lace et al.
BRAIN (2009)
Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons
David M. Yurek et al.
CELL TRANSPLANTATION (2009)
Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α-synuclein complex by Hip
Cintia Roodveldt et al.
EMBO JOURNAL (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease
D. E. Vaillancourt et al.
NEUROLOGY (2009)
Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy
Ammar Al-Chalabi et al.
PLOS ONE (2009)
Neuropathology of non-motor features of Parkinson disease
Dennis W. Dickson et al.
PARKINSONISM & RELATED DISORDERS (2009)
Genomic investigation of α-synuclein multiplication and parkinsonism
Owen A. Ross et al.
ANNALS OF NEUROLOGY (2008)
Olfactory deficits in mice overexpressing human wildtype α-synuclein
Sheila M. Fleming et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Transgenic animal models of neurodegenerative diseases and their application to treatment development
Edward Rockenstein et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Andreas Muhs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease
Chang Yi Wang et al.
VACCINE (2007)
Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease
H. Koike et al.
GENE THERAPY (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Neurological and neurodegenerative alterations in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter:: Implications for multiple system atrophy
CW Shults et al.
JOURNAL OF NEUROSCIENCE (2005)
Grading of neuropathology in multiple system atrophy: Proposal for a novel scale
KA Jellinger et al.
MOVEMENT DISORDERS (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Heat shock protein 70 inhibits α-synuclein fibril formation via preferential binding to prefibrillar species
MM Dedmon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mouse model of multiple system atrophy α-synuclein expression in oligodendrocytes causes glial and neuronal degeneration
I Yazawa et al.
NEURON (2005)
Lipid rafts mediate the synaptic localization of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2004)
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations
T Ozawa et al.
BRAIN (2004)
Behavioral characterization in a comprehensive mouse test battery reveals motor and sensory impairments in growth-associated protein-43 null mutant mice
GA Metz et al.
NEUROSCIENCE (2004)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Active Immunization of Mice with an A beta-Hsp70 Vaccine
Michael F. Koller et al.
NEURODEGENERATIVE DISEASES (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Caught in the act:: α-synuclein is the culprit in Parkinson's disease
JL Eriksen et al.
NEURON (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases
M Hashimoto et al.
NEUROMOLECULAR MEDICINE (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Cerebellar role in fear-conditioning consolidation
B Sacchetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Roles of heat-shock proteins in innate and adaptive immunity
P Srivastava
NATURE REVIEWS IMMUNOLOGY (2002)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Synucleinopathies - Clinical and pathological implications
JE Galvin et al.
ARCHIVES OF NEUROLOGY (2001)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
分享论文
